Bristol-Myers Squibb Company
Location
New Jersey
Founded
1887-04-10
Website
Risk Signals
10470 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Bristol-Myers Squibb Company
Live alerts from global media, monitored by Business Radar
2024-09-03 (ceo.ca)
Britannia Life Sciences Inc. Reports Fourth Quarter and Fiscal Year Financial Results for 2024, by @newsfile
Toronto, Ontario--(Newsfile Corp. - September 2, 2024) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased report its financial results for the year ended March 31, 2024. The Company 's audited annual financial statements and related management 's discussion and
Read more
2022-06-06 (bloomberglaw.com)
Bristol-Myers Gets First Nod for $11 Million HIV Drug Settlement
Bristol-Myers Squibb Co. inched closer to exiting antitrust litigation over Gilead Sciences Inc. 's blockbuster HIV drugs, when a federal judge in San Francisco granted preliminary approval to its$ 11 million class action settlement with wholesalers
Read more
2022-06-06 (bloomberglaw.com)
Bristol-Myers Gets First Nod for $11 Million HIV Drug Settlement
Bristol-Myers Squibb Co. inched closer to exiting antitrust litigation over Gilead Sciences Inc. 's blockbuster HIV drugs, when a federal judge in San Francisco granted preliminary approval to its$ 11 million class action settlement with wholesalers
Read more
2022-06-06 (bloomberglaw.com)
Bristol-Myers Gets First Nod for $11 Million HIV Drug Settlement
Bristol-Myers Squibb Co. inched closer to exiting antitrust litigation over Gilead Sciences Inc. 's blockbuster HIV drugs, when a federal judge in San Francisco granted preliminary approval to its$ 11 million class action settlement with wholesalers
Read more
2019-02-12 (businesswire.com)
Exelixis Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and full year 2018 and provided an update on progress toward ful
Read more
2015-10-05 (sec.gov)
SEC Charges Bristol-Myers Squibb With FCPA Violations
05-10-2015 · The SEC’s order finds that Bristol-Myers Squibb violated the FCPA’s internal controls and recordkeeping provisions. Without admitting or denying the findings, Bristol-Myers Squibb consented to the order and agreed to return$ 11.4 million
Read more
2015-10-05 (sec.gov)
SEC Charges Bristol-Myers Squibb With FCPA Violations
05-10-2015 · The SEC’s order finds that Bristol-Myers Squibb violated the FCPA’s internal controls and recordkeeping provisions. Without admitting or denying the findings, Bristol-Myers Squibb consented to the order and agreed to return$ 11.4 million
Read more